Literature DB >> 22840346

Atherosclerotic risk factors and their association with hospital mortality among patients with first myocardial infarction (from the National Registry of Myocardial Infarction).

John G Canto1, Catarina I Kiefe, William J Rogers, Eric D Peterson, Paul D Frederick, William J French, C Michael Gibson, Charles V Pollack, Joseph P Ornato, Robert J Zalenski, Jan Penney, Alan J Tiefenbrunn, Philip Greenland.   

Abstract

Few studies have examined associations between atherosclerotic risk factors and short-term mortality after first myocardial infarction (MI). Histories of 5 traditional atherosclerotic risk factors at presentation (diabetes, hypertension, smoking, dyslipidemia, and family history of premature heart disease) and hospital mortality were examined among 542,008 patients with first MIs in the National Registry of Myocardial Infarction (1994 to 2006). On initial MI presentation, history of hypertension (52.3%) was most common, followed by smoking (31.3%). The least common risk factor was diabetes (22.4%). Crude mortality was highest in patients with MI with diabetes (11.9%) and hypertension (9.8%) and lowest in those with smoking histories (5.4%) and dyslipidemia (4.6%). The inclusion of 5 atherosclerotic risk factors in a stepwise multivariate model contributed little toward predicting hospital mortality over age alone (C-statistic = 0.73 and 0.71, respectively). After extensive multivariate adjustments for clinical and sociodemographic factors, patients with MI with diabetes had higher odds of dying (odds ratio [OR] 1.23, 95% confidence interval [CI] 1.20 to 1.26) than those without diabetes and similarly for hypertension (OR 1.08, 95% CI 1.06 to 1.11). Conversely, family history (OR 0.71, 95% CI 0.69 to 0.73), dyslipidemia (OR 0.62, 95% CI 0.60 to 0.64), and smoking (OR 0.85, 95% CI 0.83 to 0.88) were associated with decreased mortality (C-statistic = 0.82 for the full model). In conclusion, in the setting of acute MI, histories of diabetes and hypertension are associated with higher hospital mortality, but the inclusion of atherosclerotic risk factors in models of hospital mortality does not improve predictive ability beyond other major clinical and sociodemographic characteristics.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22840346      PMCID: PMC4494670          DOI: 10.1016/j.amjcard.2012.06.025

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  11 in total

1.  A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II substudy.

Authors:  D A Morrow; E M Antman; R P Giugliano; R Cairns; A Charlesworth; S A Murphy; J A de Lemos; C H McCabe; E Braunwald
Journal:  Lancet       Date:  2001-11-10       Impact factor: 79.321

2.  The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making.

Authors:  E M Antman; M Cohen; P J Bernink; C H McCabe; T Horacek; G Papuchis; B Mautner; R Corbalan; D Radley; E Braunwald
Journal:  JAMA       Date:  2000-08-16       Impact factor: 56.272

3.  Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study.

Authors:  W B KANNEL; T R DAWBER; A KAGAN; N REVOTSKIE; J STOKES
Journal:  Ann Intern Med       Date:  1961-07       Impact factor: 25.391

4.  Number of coronary heart disease risk factors and mortality in patients with first myocardial infarction.

Authors:  John G Canto; Catarina I Kiefe; William J Rogers; Eric D Peterson; Paul D Frederick; William J French; C Michael Gibson; Charles V Pollack; Joseph P Ornato; Robert J Zalenski; Jan Penney; Alan J Tiefenbrunn; Philip Greenland
Journal:  JAMA       Date:  2011-11-16       Impact factor: 56.272

5.  TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy.

Authors:  D A Morrow; E M Antman; A Charlesworth; R Cairns; S A Murphy; J A de Lemos; R P Giugliano; C H McCabe; E Braunwald
Journal:  Circulation       Date:  2000-10-24       Impact factor: 29.690

6.  Major risk factors as antecedents of fatal and nonfatal coronary heart disease events.

Authors:  Philip Greenland; Maria Deloria Knoll; Jeremiah Stamler; James D Neaton; Alan R Dyer; Daniel B Garside; Peter W Wilson
Journal:  JAMA       Date:  2003-08-20       Impact factor: 56.272

7.  Prevalence of conventional risk factors in patients with coronary heart disease.

Authors:  Umesh N Khot; Monica B Khot; Christopher T Bajzer; Shelly K Sapp; E Magnus Ohman; Sorin J Brener; Stephen G Ellis; A Michael Lincoff; Eric J Topol
Journal:  JAMA       Date:  2003-08-20       Impact factor: 56.272

8.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.

Authors:  Salim Yusuf; Steven Hawken; Stephanie Ounpuu; Tony Dans; Alvaro Avezum; Fernando Lanas; Matthew McQueen; Andrzej Budaj; Prem Pais; John Varigos; Liu Lisheng
Journal:  Lancet       Date:  2004 Sep 11-17       Impact factor: 79.321

9.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

Authors:  S M Haffner; S Lehto; T Rönnemaa; K Pyörälä; M Laakso
Journal:  N Engl J Med       Date:  1998-07-23       Impact factor: 91.245

10.  Predictors of hospital mortality in the global registry of acute coronary events.

Authors:  Christopher B Granger; Robert J Goldberg; Omar Dabbous; Karen S Pieper; Kim A Eagle; Christopher P Cannon; Frans Van De Werf; Alvaro Avezum; Shaun G Goodman; Marcus D Flather; Keith A A Fox
Journal:  Arch Intern Med       Date:  2003-10-27
View more
  15 in total

1.  Anginal symptoms, coronary artery disease, and adverse outcomes in Black and White women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study.

Authors:  Jo-Ann Eastwood; B Delia Johnson; Thomas Rutledge; Vera Bittner; Kerry S Whittaker; David S Krantz; Carol E Cornell; Wafia Eteiba; Eileen Handberg; Diane Vido; C Noel Bairey Merz
Journal:  J Womens Health (Larchmt)       Date:  2013-08-30       Impact factor: 2.681

2.  Sex Differences in Cardiac Risk Factors, Perceived Risk, and Health Care Provider Discussion of Risk and Risk Modification Among Young Patients With Acute Myocardial Infarction: The VIRGO Study.

Authors:  Erica C Leifheit-Limson; Gail D'Onofrio; Mitra Daneshvar; Mary Geda; Héctor Bueno; John A Spertus; Harlan M Krumholz; Judith H Lichtman
Journal:  J Am Coll Cardiol       Date:  2015-11-03       Impact factor: 24.094

3.  Significance of preoperative left ventricular ejection fraction in 5-year outcome after isolated CABG.

Authors:  Aida Fallahzadeh; Ali Sheikhy; Ali Ajam; Saeed Sadeghian; Mina Pashang; Mahmoud Shirzad; Jamshid Bagheri; Soheil Mansourian; Shahram Momtahen; Kaveh Hosseini
Journal:  J Cardiothorac Surg       Date:  2021-12-27       Impact factor: 1.637

4.  Smoking status and life expectancy after acute myocardial infarction in the elderly.

Authors:  Emily M Bucholz; Adam L Beckman; Catarina I Kiefe; Harlan M Krumholz
Journal:  Heart       Date:  2015-11-23       Impact factor: 5.994

Review 5.  Population-level differences in revascularization treatment and outcomes among various United States subpopulations.

Authors:  Garth Graham; Yang-Yu Karen Xiao; Dan Rappoport; Saima Siddiqi
Journal:  World J Cardiol       Date:  2016-01-26

6.  Impact of family history of coronary artery disease on in-hospital clinical outcomes in ST-segment myocardial infarction.

Authors:  Manyoo A Agarwal; Lohit Garg; Carl J Lavie; Guy L Reed; Rami N Khouzam
Journal:  Ann Transl Med       Date:  2018-01

7.  Prognostic significance of incident atrial fibrillation following STEMI depends on the timing of atrial fibrillation.

Authors:  P Gal; E Parlak; F Demirel; A Adiyaman; J Ten Berg; A W J van 't Hof; A Elvan
Journal:  Neth Heart J       Date:  2015-08       Impact factor: 2.380

8.  Prevalence of conventional risk factors and lipid profiles in patients with acute coronary syndrome and significant coronary disease.

Authors:  Héctor González-Pacheco; Jesús Vargas-Barrón; Maite Vallejo; Yigal Piña-Reyna; Alfredo Altamirano-Castillo; Pedro Sánchez-Tapia; Carlos Martínez-Sánchez
Journal:  Ther Clin Risk Manag       Date:  2014-10-06       Impact factor: 2.423

9.  Association of various risk factors with prognosis and hospitalization cost in Chinese patients with acute myocardial infarction: A clinical analysis of 627 cases.

Authors:  Peining Wang; Bin Zhang; Lijun Jin; Hongtao Liao; Taiming Dong
Journal:  Exp Ther Med       Date:  2014-11-24       Impact factor: 2.447

10.  The chromosome 9p21 variant not predicting long-term cardiovascular mortality in Chinese with established coronary artery disease: an eleven-year follow-up study.

Authors:  I-Te Lee; Mark O Goodarzi; Wen-Jane Lee; Jerome I Rotter; Yii-der Ida Chen; Kae-Woei Liang; Wen-Lieng Lee; Wayne H-H Sheu
Journal:  Biomed Res Int       Date:  2014-04-02       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.